Bariks is revolutionizing Hyperbaric Oxygen Therapy (HBOT) with a groundbreaking portable and foldable oxygen pressure chamber, delivering treatment at up to 3 ATA working pressure.
Vision and Value Proposition
Our mission is to make HBOT treatments fully accessible anywhere in the world with the Possibility to enhancing and save life. Bariks’ innovative chamber, along with all necessary components and accessories, fits into just two suitcases, enabling easy transport and setup.
The Problem
Current hyperbaric oxygen therapy (HBOT) chambers for treatments above 2 ATA are stationary and primarily located in hospitals. This setup forces patients to travel, making access inconvenient and time-consuming, especially for a full treatment course of 30-40 sessions. For athletes, who are frequently on the move, this lack of mobility restricts their ability to undergo therapy. In emergencies, where immediate access is crucial, the limited availability and fixed nature of these chambers prevent timely intervention, leading to missed opportunities for treatment and saving lives. This inaccessibility represents a significant market gap and an unmet need in the healthcare, sports industries and more.
Business Model
Bariks has developed all technological components of the chamber in-house, including proprietary software, resulting in low production costs. This positions us to leverage two business models:
1. Direct Sales: Offering the chamber at high margins.
2. Leasing: Featuring an initial setup fee and a fixed monthly payment.
These models provide flexibility and scalability, catering to different market segments and maximizing revenue potential
Solution
Our groundbreaking technology redefines HBOT by combining portability with high functionality. Bariks has developed a lightweight, foldable, and portable chamber capable of supporting treatments at pressures up to 3 ATA. By minimizing the size of all components, including a unique turbo compressor and digital software. We’ve created a fully self-contained product. This innovation offers unmatched versatility, allowing patients and athletes to undergo therapy wherever they are, with maximum comfort. Bariks is poised to transform the HBOT industry by making treatment more accessible, driving demand, and unlocking new market opportunities.
Market Opportunity
The hyperbaric oxygen therapy market (above 2 ATA) is experiencing rapid growth, driven by new applications like sports injuries, stroke recovery, cognitive enhancement, and longevity, alongside traditional uses such as diabetic wounds and diving accidents. Expected to exceed $10 billion by 2030, the market is seeing unprecedented demand, fuelled by influencers and elite athletes adopting the therapy. Bariks’ portable, comfortable, and personalized chamber is perfectly positioned to meet and drive this demand, enabling the sale of hundreds of units annually. For instance, a Tour de France team could now provide daily hyperbaric treatment to its riders, enhancing performance and recovery.
Product Innovation Showcase
Bariks Roadmap
CE approval, Mass production and deployment of the first chambers
Reach over 100 chambers in full deployment. FDA applications
CE approval, Mass production and deployment of the first chambers
CE approval, Mass production and deployment of the first chambers
Following four years of dedicated innovation and refinement,
Bariks chambers are strategically positioned to enter the market in Q1 2025,
marking a significant milestone in our growth trajectory.
Bariks Leading Team
Founder:
(Admiral) Yedidya Ya’ari
Former CEO of Rafael…
Read More
Former CEO of Rafael Advanced Defense Systems, led the development of the Iron Dome, Chairman of Aeronautics Group, and former Commander of the Israeli Navy.
Founder & Chairman:
Boaz Misholi
One of Israel’s high-tech pioneers. Founder and ex-CEO of Comverse Tech (NASDAQ: CMVT), Founder & Chairman of FundTech (NASDAQ: FNDT), and VersaMed (sold to GE).
Founder & Medical
Director:
Dr. Yehuda Melamed
Global leader in hyperbaric medicine. Founder of the Israeli Naval Medical Institute and multiple hyperbaric centers in Israel and around the world.
Founder and Co-CEO:
Amir Shukrun
Extensive experience in business development for startups, with a strong track record in private equity, mergers, and mezzanine loans. Holds an MBA from Tel Aviv University.
Co-CEO:
Michael Smadja
Extensive experience in global medical equipment management, leading roles at GE Medical, West Pharma, and VersaMed.
COO:
Rami Bargil
VP of Operations with 20+ years in software engineering and international project leadership, including Intel. Let me know if this works for you!
Contact Us
*Disclaimer* The information presented in this website is for informational purposes only and does not constitute an offer, solicitation, or recommendation to buy or sell securities or engage in any investment activity. Any investment decisions should be made after careful consideration of individual circumstances and in consultation with professional advisors. This presentation may contain forward-looking statements that involve risks and uncertainties, and actualresults may differ materially from those expressed or implied. We do not guarantee the accuracy, completeness, or reliability of any information presented herein. Anyreliance on the information provided in this presentation is at the viewer’s own risk. We disclaim any liability for any loss or damage arising directly or indirectly from the use of or reliance on this presentation or its contents.